Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04801797
Title Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
Stanford Cancer Center RECRUITING Palo Alto California 94304 United States Details
University of California - Davis RECRUITING Sacramento California 95817 United States Details
Massachusetts General Hospital Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Atrium Health Levine Cancer Institute RECRUITING Charlotte North Carolina 28204 United States Details
Ohio State University Medical Center RECRUITING Columbus Ohio 43210 United States Details
University of Pennsylvania RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from for the field